However, a study of head and neck squamous cell carcinoma suggested that an increase in serum VEGF-A levels is a significant negative predictor of radiotherapy or chemoradiotherapy (P = 0.001) (32). The gene discussed is VEGFA; the disease is head and neck squamous cell carcinoma.